Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Chemoradiotherapy in Head and Neck Cancer
NCT00703976Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Oct 2008
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Pittsburgh. Started Oct 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00703976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703976.